| Literature DB >> 35610570 |
Yuanli Lei1, Jinying Liu1, Yi Lin2, Huiping Li3, Wenxing Song1, Zhangping Li1, Weijia Huang1, Shouquan Chen4.
Abstract
BACKGROUND: Spontaneous isolated superior mesenteric artery (SMA) dissection (SISMAD) is a rare disease with a potentially fatal pathology. Due to the lack of specificity of clinical characteristics and laboratory tests, misdiagnosis and missed diagnosis are often reported. Therefore, the aim of this study was to investigate the clinical characteristics and misdiagnosis of SISMAD.Entities:
Keywords: Abdominal pain; Clinical characteristics; Misdiagnosis; Spontaneous isolated superior mesenteric artery dissection
Mesh:
Year: 2022 PMID: 35610570 PMCID: PMC9131659 DOI: 10.1186/s12872-022-02676-9
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.174
Fig. 1Number of SISMAD patients from 2013 to 2020. SISMAD, spontaneous isolated superior mesenteric artery dissection
Fig. 2Features of Yun types I and III Dissection. (A) Axial CTA showing the characteristic finding of the double-lumen sign of the SMA below the LRV plane. (B) Sagittal CTA showing that the true and false lumens were separated by an intimal flap (black arrow). (C) CTA volume rendering showing the true and false lumens. (D) Longitudinal CTA showing the entry and re-entry sites. (E) Sagittal CTA showing complete occlusion of the SMA. (F) DSA showing complete occlusion of the SMA. The yellow arrow represents the true lumen; the white arrow represents the false lumen; the blue arrow represents the entry site or re-entry site; and the red arrow shows complete occlusion of the SMA. CTA computed tomography angiography, SMA superior mesenteric artery, LRV left renal vein, DSA digital subtraction angiography
Fig. 3Features of Yun type IIb dissection. Axial CECT showing the true and thrombosed false lumens above the LRV plane (A) and the cyst-like residual false lumen in the thrombosed false lumen on the LRV (pink arrow) plane (B). Longitudinal CTA showing unthrombosed false lumen (black arrow) and thrombosed false lumen (C) and two cyst-like residual false lumens (D), one cyst-like residual false lumen (E), and no residual false lumen (G) in the thrombosed false lumen. CTA volume rendering (F) showing a cyst-like residual false lumen in the thrombosed false lumen. The yellow arrow represents the true lumen; the white arrow represents the thrombosed false lumen; and the blue arrow represents the cyst-like residual false lumen. CECT contrast-enhanced computed tomography, LRV left renal vein, CTA computed tomography angiography
Clinical characteristics of SISMAD (N = 110)
| Variables | N (%) |
|---|---|
| Comorbidities | |
| Hypertension | 43 (39.1) |
| Liver-relative disease | 15 (13.6) |
| Chronic hepatitis B | 7 (6.4) |
| Hepatic adipose infiltration | 6 (5.5) |
| Alcoholic liver disease | 1 (0.9) |
| Hepatic insufficiency | 1 (0.9) |
| Lung mass | 4 (3.6) |
| Gout | 4 (3.6) |
| Sinus bradycardia | 4 (3.6) |
| Right bundle branch block | 2 (1.8) |
| Hyperlipemia | 2 (1.8) |
| Diabetes mellitus | 0 (0.0) |
| Smoking | 46 (41.8) |
| Alcohol consumption | 34 (30.9) |
| Clinical symptoms | |
| Duration (d) | |
| 0.04–60 | 1 (0.4–3.0) |
| Abdominal pain | 104 (94.5) |
| Back pain | 6 (5.5) |
| Low back pain | 6 (5.5) |
| Chest pain | 2 (1.8) |
| Systolic pressure ≥ 140 mmHg during the first hospital visit | 59 (53.6) |
| Diastolic pressure ≥ 90 mmHg during the first hospital visit | 55 (50.0) |
| Acute abdomen | 35 (31.8) |
| Urinary calculi | 14 (12.7) |
| Gallstone/cholecystitis | 9 (8.2) |
| Intestinal obstruction | 8 (7.3) |
| Bowel necrosis | 4 (3.6) |
| Ischemic enteropathy | 3 (2.7) |
| Appendicitis | 2 (1.8) |
| Acute gastroenteritis | 2 (1.8) |
| Others* | 3 (2.7) |
SISMAD spontaneous isolated superior mesenteric artery dissection
*Others included pancreatitis, inguinal hernia, and enteric infection
Laboratory data in cases of SISMAD
| Variables | Total | Abnormal findings* | Normal range | ||
|---|---|---|---|---|---|
| N | Values | N (%) | Values | Normal range | |
| C-reactive protein (mg/l) | 81 | 13.2 (5–29.3) | 47 (58.0) | 25.2 (16.2–39.6) | 0.00–10.00 |
| White blood cells (× 109/l) | 110 | 9.93 ± 3.71 | 50 (45.5) | 13.05 ± 3.10 | 3.50–9.50 |
| D-dimer (mg/l) | 102 | 0.38 (0.24–0.74) | 34 (33.3) | 1.04 ± 0.38 | 0.00–0.50 |
| Total cholesterol (mmol/l) | 105 | 4.81 ± 1.15 | 34 (32.4) | 6.16 ± 0.85 | 2.44–5.17 |
| Glycerin trilaurate (mmol/l) | 108 | 1.25 (0.98–1.90) | 33 (30.6) | 2.73 ± 1.38 | 0.40–1.70 |
| Low density lipoprotein cholesterol (mmol/l) | 108 | 2.75 ± 0.90 | 33 (30.6) | 3.82 ± 0.65 | 2.07–3.10 |
| 24 (22.2) | 1.72 ± 0.36 | ||||
| Serum creatinine (μmol/l) | 110 | 70.12 ± 14.91 | 23 (20.9) | 50.87 ± 5.83 | 58–110 |
| Serum lactate (mmol/l) | 43 | 1.71 ± 0.97 | 9 (20.9) | 3.30 ± 0.82 | 0.7–2.1 |
| Serum Amylase (u/l) | 69 | 80.20 ± 27.55 | 13 (18.8) | 121.85 ± 21.74 | 28–100 |
| Troponin I (μg/l) | 63 | 0.002 (0.001–0.006) | 1 (1.6) | 1.17 | 0.000–0.150 |
Values are expressed as median (interquartile range) or mean ± standard deviation
SISMAD spontaneous isolated superior mesenteric artery dissection
*Abnormal findings: all of the variables were either above the normal upper limit or below the normal lower limit, except low-density lipoprotein cholesterol (33 values were above the normal upper limit and 24 values were below the normal lower limit)
Diagnostic method for or proof of SISMAD (N = 110)
| Diagnostic method for or proof of SISMAD | N (%) |
|---|---|
| Imaging examination at another hospital showed disease of the SMA | 41 (37.3) |
| Suspected aortic dissection; patient underwent abdominal aortic CTA | 10 (9.1) |
| Plain CT showed changes to the SMA; patient underwent CTA | 17 (15.5) |
| Plain CT findings suggested that CECT should be performed next | 3 (2.7) |
| Plain CT findings could not explain the clinical symptoms; patient underwent CECT | 35 (31.8) |
| Plain CT findings were negative | 22 (20.0) |
| Plain CT findings were positive but did not include the above findings | 13 (11.8) |
| Other* | 4 (3.6) |
*Other: One patient was diagnosed with scapulohumeral periarthritis and then underwent positron emission tomography-CT, the findings of which showed SISMAD. Three patients complained of recurrent abdominal pain and were diagnosed with gastrointestinal dysfunction. These patients underwent gastroenterological endoscopy; however, the findings were negative, so they underwent CECT or CTA. SISMAD spontaneous isolated superior mesenteric artery dissection, SMA superior mesenteric artery, CTA computed tomography angiography, CT computed tomography, CECT contrast-enhanced computed tomography, DSA digital subtraction angiography
Analysis of misdiagnosis and missed diagnosis (N = 32)
| Type | Cause classification | Diseases of misdiagnosis | Imaging tests with reporting problems | Yun Classification | N (%) |
|---|---|---|---|---|---|
| Misdiagnosis (N = 28) | Insufficient awareness (N = 14) | Gastrointestinal dysfunction | – | IIb | 3 (9.4) |
| Urinary calculi | – | IIb | 1 (3.1) | ||
| III | 1 (3.1) | ||||
| Acute gastritis | – | IIb | 1 (3.1) | ||
| Scapulohumeral periarthritis | – | IIb | 1 (3.1) | ||
| Mesenteric vein thrombosis | CECT | IIa | 1 (3.1) | ||
| SMA embolism | CECT | IIb | 4 (12.5) | ||
| CECT | III | 1 (3.1) | |||
| CTA | IIb | 1 (3.1) | |||
| Disease features (N = 12) | SMA embolism | CECT | IIa | 1 (3.1) | |
| IIb | 6 (18.8) | ||||
| III | 2 (6.3) | ||||
| CTA | IIb | 1 (3.1) | |||
| III | 1 (3.1) | ||||
| Abdominal aortic CTA | IIb | 1 (3.1) | |||
| Imaging quality (N = 2) | SMA embolism | CECT | IIb | 1 (3.1) | |
| CTA | 1 (3.1) | ||||
| Missed diagnosis (N = 4) | Insufficient awareness (N = 3) | CECT | I | 1 (3.1) | |
| CECT | IIb | 1 (3.1) | |||
| CECT | III | 1 (3.1) | |||
| Disease features (N = 1) | CTA | IIa | 1 (3.1) |
SMA superior mesenteric artery, CECT contrast-enhanced computed tomography, CTA computed tomography angiography
Dissection features on plain CT (N = 66)
| Maximum SMA diameter (mm) | Location of maximum SMA diameter | Perivascular exudation | |||
|---|---|---|---|---|---|
| Above the LRV plane | on the LRV plane | Below the LRV plane | |||
| Values | 12.1 (11.3–13.1) | 18 (27.3) | 45 (68.2) | 3 (4.5) | 44 (66.7) |
Values are expressed as median (interquartile range) or the no. (%)
CT computed tomography, SMA superior mesenteric artery, LRV left renal vein
Relationship between dissection features and treatment modality (N = 110)
| Variables | N (%) | Conservative group (n = 71) | Non-conservative group (n = 39) | t/χ2 | P-value |
|---|---|---|---|---|---|
| Ostium to dissection entry, mm | 15.1 ± 9.1 | 15.4 ± 8.9 | 14.4 ± 9.7 | 0.555 | 0.580 |
| Dissection length, mm | 91.9 ± 33.1 | 93.0 ± 30.3 | 89.7 ± 37.9 | 0.501 | 0.618 |
| Residual true lumen diameter, mm | 2.7 ± 1.6 | 2.9 ± 1.6 | 2.3 ± 1.6 | 2.069 | 0.041 |
| Degree of true lumen stenosis, % | 8.929 | 0.012 | |||
| < 50% | 43 (39.1) | 35 (49.3) | 8 (20.5) | ||
| ≥ 50% and ≤ 70% | 32 (29.1) | 18 (25.4) | 14 (35.9) | ||
| > 70% | 35 (31.8) | 18 (25.4) | 17 (43.6) | ||
| Maximum SMA diameter, mm | 13.0 ± 2.4 | 13.2 ± 2.5 | 12.6 ± 2.2 | 1.401 | 0.164 |
| Location of maximum SMA diameter | 0.959 | 0.619 | |||
| Above the LRV plane | 35 (31.8) | 21 (29.6) | 14 (35.9) | ||
| on the LRV plane | 71 (64.5) | 48 (67.6) | 23 (59.0) | ||
| Below the LRV plane | 4 (3.6) | 2 (2.8) | 2 (5.1) | ||
| Aortomesenteric angle, ° | 76.3 ± 25.0 | 75.6 ± 25.0 | 77.6 ± 25.1 | − 0.404 | 0.687 |
| Classification | 1.732 | 0.630 | |||
| I | 16 (14.5) | 10 (14.1) | 6 (15.4) | ||
| IIa | 6 (5.5) | 5 (7.0) | 1 (2.6) | ||
| IIb | 70 (63.6) | 46 (64.8) | 24 (61.5) | ||
| III | 18 (16.4) | 10 (14.1) | 8 (20.5) | ||
| Celiac trunk dissection | 8 (7.3) | 5 (7.0) | 3 (7.7) | 0.000 | 1.000 |
| Iliac artery dissection | 2 (1.8) | 1 (1.4) | 1 (2.6) | – | 1.000 |
| Renal artery dissection | 1 (0.9) | 1 (1.4) | 0 (0.0) | – | 1.000 |
| Intestinal obstruction | 8 (7.3) | 2 (2.8) | 6 (15.4) | 4.179 | 0.041 |
| Bowel necrosis | 4 (3.6) | 0 (0.0) | 4 (10.3) | 4.913 | 0.027 |
SMA superior mesenteric artery, LRV left renal vein
Treatment modality (N = 110)
| Treatment modalities | N (%) |
|---|---|
| Conservative treatment | 71 (64.5) |
| Endovascular bare stent after 2 months of follow-up | 2 (1.8) |
| Non-conservative treatment | 39 (35.5) |
| Endovascular bare stent | 31 (28.2) |
| Balloon dilation assisting bare stent | 8 (7.3) |
| Coil assisting bare stent | 1 (0.9) |
| Interventional thrombolysis | 4 (3.6) |
| Open surgical treatment | 4 (3.6) |
| Bare stent assisting surgical treatment | 1 (0.9) |